[Flow cytometric analysis of DNA in esophageal cancer]. 1992

D C Wu, and L T Chen, and M S Huang, and C M Jan, and W M Wang, and C S Liu, and H J Lin, and C Y Chen
Department of Internal Medicine, Kaohsiung Medical College, Taiwan, Republic of China.

Malignancy is the first of the ten leading causes of death in Taiwan area, however, since 1978, esophageal cancer is on the first ten causes of malignancy. Esophageal cancer is an aggressive neoplasm with a generally poor prognosis. This is usually related to the advanced stages of the neoplasm at presentation and at diagnosis. In this study, the DNA content in tumor was analyzed by flow cytometry, and compared it with clinical- pathological data, especially the survival time. All thirty seven cases (36 male, 1 female, mean age: 56.5 +/- 10.3 y/o) received operation at Kaohsiung Medical College Hospital in the past 11 years and 29 cases (27 male, 2 female, mean age: 62.2 +/- 9.6 y/o) proved to be esophageal cancer by endoscopic biopsy were assayed in this study. The formalin fixed-paraffin embedded block is used to analyze DNA content by flow cytometry. After comparing these results with clinical-pathological data, there were no significant difference in sex, age, duration, tumor location and length. However, there is a significant correlation between ploidy and tumor cell differentiation, that is, most of the diploid cells were well differentiated while most of the aneuploid cells were poorly differentiated. The median survival time of diploid cases was 325 days which was longer than the 277 days in aneuploid group, but there was no significant difference between these two groups. The same result was noticed in DNA index. Multiple variables analysis of prognostic factors disclosed that there were significant difference in correation with age tumor location tumor length, and whether there was combined radiotherapy and operation. But there were no significant relationship between survival and DNA ploidy DNA index distant metastasis surrounding tissue invasion sex duration and tumor cell differentiation. These data suggest that DNA folw cytometry analysis alone, may not provide a sueful biologic basis for the variable prognosis seen with esophageal tumors.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011003 Ploidies The degree of replication of the chromosome set in the karyotype. Ploidy
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

D C Wu, and L T Chen, and M S Huang, and C M Jan, and W M Wang, and C S Liu, and H J Lin, and C Y Chen
October 1993, Journal of surgical oncology,
D C Wu, and L T Chen, and M S Huang, and C M Jan, and W M Wang, and C S Liu, and H J Lin, and C Y Chen
March 1988, The Australian and New Zealand journal of surgery,
D C Wu, and L T Chen, and M S Huang, and C M Jan, and W M Wang, and C S Liu, and H J Lin, and C Y Chen
December 1993, Cancer,
D C Wu, and L T Chen, and M S Huang, and C M Jan, and W M Wang, and C S Liu, and H J Lin, and C Y Chen
September 1989, Nihon Geka Gakkai zasshi,
D C Wu, and L T Chen, and M S Huang, and C M Jan, and W M Wang, and C S Liu, and H J Lin, and C Y Chen
December 1991, Gastroenterology,
D C Wu, and L T Chen, and M S Huang, and C M Jan, and W M Wang, and C S Liu, and H J Lin, and C Y Chen
January 1990, Clinical laboratory science : journal of the American Society for Medical Technology,
D C Wu, and L T Chen, and M S Huang, and C M Jan, and W M Wang, and C S Liu, and H J Lin, and C Y Chen
May 1985, European journal of respiratory diseases,
D C Wu, and L T Chen, and M S Huang, and C M Jan, and W M Wang, and C S Liu, and H J Lin, and C Y Chen
June 1990, The Journal of laryngology and otology,
D C Wu, and L T Chen, and M S Huang, and C M Jan, and W M Wang, and C S Liu, and H J Lin, and C Y Chen
October 1992, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
D C Wu, and L T Chen, and M S Huang, and C M Jan, and W M Wang, and C S Liu, and H J Lin, and C Y Chen
October 1992, The Tohoku journal of experimental medicine,
Copied contents to your clipboard!